Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
JAMA
|
September 26, 1980
Morphine acetate
G K Poochikian, J C Cradock, J P Davignon
Cancer Treatment Reports
|
January 1, 1978
Pharmaceutical assessment of amygdalin (Laetrile) products
J P Davignon, L A Trissel, L M Kleinman
Cancer Chemotherapy Reports. Part 3
|
May 1, 1973
Formulation of three nitrosoureas for intravenous use
J P Davignon, K W Yang, H B Wood, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1973
An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant
J C Cradock, J P Davignon, C L Litterst, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs
J P Davignon, J A Slack, J H Beijnen, et al.
Investigational New Drugs
|
January 1, 1983
Spiromustine: a new agent entering clinical trials
D D Shoemaker, P J O'Dwyer, S Marsoni, et al.
Cancer Treatment Reports
|
January 1, 1978
Psychotropic drugs as potential antitumor agents: a selective screening study
J S Driscoll, N R Melnick, F R Quinn, et al.
Investigational New Drugs
|
January 1, 1984
Tiazofurin: a new antitumor agent
P J O'Dwyer, D D Shoemaker, H N Jayaram, et al.
The New England Journal of Medicine
|
January 28, 1982
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer
C G Moertel, T R Fleming, J Rubin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
JAMA
|
September 26, 1980
Morphine acetate
G K Poochikian, J C Cradock, J P Davignon
Cancer Treatment Reports
|
January 1, 1978
Pharmaceutical assessment of amygdalin (Laetrile) products
J P Davignon, L A Trissel, L M Kleinman
Cancer Chemotherapy Reports. Part 3
|
May 1, 1973
Formulation of three nitrosoureas for intravenous use
J P Davignon, K W Yang, H B Wood, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1973
An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant
J C Cradock, J P Davignon, C L Litterst, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs
J P Davignon, J A Slack, J H Beijnen, et al.
Investigational New Drugs
|
January 1, 1983
Spiromustine: a new agent entering clinical trials
D D Shoemaker, P J O'Dwyer, S Marsoni, et al.
Cancer Treatment Reports
|
January 1, 1978
Psychotropic drugs as potential antitumor agents: a selective screening study
J S Driscoll, N R Melnick, F R Quinn, et al.
Investigational New Drugs
|
January 1, 1984
Tiazofurin: a new antitumor agent
P J O'Dwyer, D D Shoemaker, H N Jayaram, et al.
The New England Journal of Medicine
|
January 28, 1982
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer
C G Moertel, T R Fleming, J Rubin, et al.
Page
of 2